nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2C9—Acetylsalicylic acid—Kawasaki disease	0.363	0.507	CbGbCtD
Promethazine—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.352	0.492	CbGbCtD
Promethazine—CALM2—artery—Kawasaki disease	0.0165	0.0662	CbGeAlD
Promethazine—CALM1—artery—Kawasaki disease	0.0164	0.0659	CbGeAlD
Promethazine—CALM2—endothelium—Kawasaki disease	0.0139	0.0559	CbGeAlD
Promethazine—CALM1—endothelium—Kawasaki disease	0.0139	0.0556	CbGeAlD
Promethazine—CALM2—gall bladder—Kawasaki disease	0.0121	0.0485	CbGeAlD
Promethazine—CALM3—cardiac ventricle—Kawasaki disease	0.0118	0.0473	CbGeAlD
Promethazine—CALM3—myocardium—Kawasaki disease	0.0111	0.0445	CbGeAlD
Promethazine—CHRM5—skin of body—Kawasaki disease	0.0109	0.0436	CbGeAlD
Promethazine—HTR2A—artery—Kawasaki disease	0.01	0.0401	CbGeAlD
Promethazine—CALM2—cardiac ventricle—Kawasaki disease	0.00925	0.0371	CbGeAlD
Promethazine—CALM1—cardiac ventricle—Kawasaki disease	0.00921	0.0369	CbGeAlD
Promethazine—CALM2—neck—Kawasaki disease	0.00919	0.0369	CbGeAlD
Promethazine—CALM1—neck—Kawasaki disease	0.00915	0.0367	CbGeAlD
Promethazine—CALM2—myocardium—Kawasaki disease	0.0087	0.0349	CbGeAlD
Promethazine—CALM1—myocardium—Kawasaki disease	0.00866	0.0348	CbGeAlD
Promethazine—HTR2A—endothelium—Kawasaki disease	0.00845	0.0339	CbGeAlD
Promethazine—CALM3—heart—Kawasaki disease	0.00773	0.031	CbGeAlD
Promethazine—CHRM2—heart—Kawasaki disease	0.00762	0.0306	CbGeAlD
Promethazine—CALM2—heart—Kawasaki disease	0.00607	0.0244	CbGeAlD
Promethazine—CALM1—heart—Kawasaki disease	0.00604	0.0243	CbGeAlD
Promethazine—CALM2—skin of body—Kawasaki disease	0.00595	0.0239	CbGeAlD
Promethazine—CALM1—skin of body—Kawasaki disease	0.00592	0.0238	CbGeAlD
Promethazine—ADRA1A—heart—Kawasaki disease	0.0057	0.0229	CbGeAlD
Promethazine—HTR2A—neck—Kawasaki disease	0.00557	0.0224	CbGeAlD
Promethazine—CYP2B6—heart—Kawasaki disease	0.00451	0.0181	CbGeAlD
Promethazine—CYP2C9—heart—Kawasaki disease	0.00447	0.0179	CbGeAlD
Promethazine—CYP2B6—skin of body—Kawasaki disease	0.00442	0.0177	CbGeAlD
Promethazine—HTR2A—heart—Kawasaki disease	0.00368	0.0148	CbGeAlD
Promethazine—CALM3—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00333	0.0937	CbGpPWpGaD
Promethazine—CALM2—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00323	0.0907	CbGpPWpGaD
Promethazine—CALM1—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00323	0.0907	CbGpPWpGaD
Promethazine—ABCB1—heart—Kawasaki disease	0.00241	0.00968	CbGeAlD
Promethazine—CALM3—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00218	0.0612	CbGpPWpGaD
Promethazine—CALM2—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00211	0.0592	CbGpPWpGaD
Promethazine—CALM1—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00211	0.0592	CbGpPWpGaD
Promethazine—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.000893	0.0251	CbGpPWpGaD
Promethazine—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.000863	0.0243	CbGpPWpGaD
Promethazine—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.000863	0.0243	CbGpPWpGaD
Promethazine—HRH4—GPCRs, Other—CCR5—Kawasaki disease	0.000741	0.0208	CbGpPWpGaD
Promethazine—HRH4—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000347	0.00975	CbGpPWpGaD
Promethazine—CALM3—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000287	0.00806	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000286	0.00805	CbGpPWpGaD
Promethazine—HTR2A—GPCRs, Other—CCR5—Kawasaki disease	0.000282	0.00792	CbGpPWpGaD
Promethazine—CHRM3—GPCRs, Other—CCR5—Kawasaki disease	0.000279	0.00786	CbGpPWpGaD
Promethazine—CALM2—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000277	0.0078	CbGpPWpGaD
Promethazine—CALM1—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000277	0.0078	CbGpPWpGaD
Promethazine—CHRM2—GPCRs, Other—CCR5—Kawasaki disease	0.000277	0.00778	CbGpPWpGaD
Promethazine—HRH4—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000276	0.00776	CbGpPWpGaD
Promethazine—CALM3—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000252	0.0071	CbGpPWpGaD
Promethazine—CALM2—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000244	0.00687	CbGpPWpGaD
Promethazine—CALM1—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000244	0.00687	CbGpPWpGaD
Promethazine—CALM3—B Cell Activation—BLK—Kawasaki disease	0.000221	0.00621	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.00022	0.00617	CbGpPWpGaD
Promethazine—CALM1—B Cell Activation—BLK—Kawasaki disease	0.000214	0.006	CbGpPWpGaD
Promethazine—CALM2—B Cell Activation—BLK—Kawasaki disease	0.000214	0.006	CbGpPWpGaD
Promethazine—HRH4—GPCR ligand binding—CCR5—Kawasaki disease	0.00021	0.00591	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.000202	0.00569	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.000199	0.00559	CbGpPWpGaD
Promethazine—CHRM4—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000195	0.00547	CbGpPWpGaD
Promethazine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000181	0.00508	CbGpPWpGaD
Promethazine—CHRM5—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000173	0.00486	CbGpPWpGaD
Promethazine—CALM1—Endochondral Ossification—MMP9—Kawasaki disease	0.000164	0.00461	CbGpPWpGaD
Promethazine—CALM2—Endochondral Ossification—MMP9—Kawasaki disease	0.000164	0.00461	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ITPKC—Kawasaki disease	0.000155	0.00435	CbGpPWpGaD
Promethazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000155	0.00435	CbGpPWpGaD
Promethazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000148	0.00417	CbGpPWpGaD
Promethazine—CALM2—Endochondral Ossification—VEGFA—Kawasaki disease	0.000147	0.00414	CbGpPWpGaD
Promethazine—CALM1—Endochondral Ossification—VEGFA—Kawasaki disease	0.000147	0.00414	CbGpPWpGaD
Promethazine—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000145	0.00408	CbGpPWpGaD
Promethazine—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00014	0.00394	CbGpPWpGaD
Promethazine—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00014	0.00394	CbGpPWpGaD
Promethazine—DRD2—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000134	0.00377	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ITPKC—Kawasaki disease	0.000133	0.00374	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ITPKC—Kawasaki disease	0.00013	0.00364	CbGpPWpGaD
Promethazine—CHRM2—G alpha (i) signalling events—CCR5—Kawasaki disease	0.00013	0.00364	CbGpPWpGaD
Promethazine—CALM3—Platelet degranulation—VEGFA—Kawasaki disease	0.000127	0.00358	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ITPKC—Kawasaki disease	0.000125	0.00353	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ITPKC—Kawasaki disease	0.000125	0.00353	CbGpPWpGaD
Promethazine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000124	0.0035	CbGpPWpGaD
Promethazine—CALM2—Platelet degranulation—VEGFA—Kawasaki disease	0.000123	0.00346	CbGpPWpGaD
Promethazine—CALM1—Platelet degranulation—VEGFA—Kawasaki disease	0.000123	0.00346	CbGpPWpGaD
Promethazine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000122	0.00344	CbGpPWpGaD
Promethazine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000122	0.00344	CbGpPWpGaD
Promethazine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000122	0.00342	CbGpPWpGaD
Promethazine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000121	0.00341	CbGpPWpGaD
Promethazine—CALM3—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000121	0.00341	CbGpPWpGaD
Promethazine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.00012	0.00338	CbGpPWpGaD
Promethazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.00012	0.00337	CbGpPWpGaD
Promethazine—HRH4—GPCR downstream signaling—CCR5—Kawasaki disease	0.000119	0.00334	CbGpPWpGaD
Promethazine—CHRM4—GPCR ligand binding—CCR5—Kawasaki disease	0.000118	0.00331	CbGpPWpGaD
Promethazine—CALM2—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000117	0.0033	CbGpPWpGaD
Promethazine—CALM1—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000117	0.0033	CbGpPWpGaD
Promethazine—CHRM5—GPCR ligand binding—CCR5—Kawasaki disease	0.000113	0.00317	CbGpPWpGaD
Promethazine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000113	0.00317	CbGpPWpGaD
Promethazine—HRH4—Signaling by GPCR—CCR5—Kawasaki disease	0.000108	0.00303	CbGpPWpGaD
Promethazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000107	0.003	CbGpPWpGaD
Promethazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000105	0.00295	CbGpPWpGaD
Promethazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000105	0.00294	CbGpPWpGaD
Promethazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000104	0.00293	CbGpPWpGaD
Promethazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000104	0.00292	CbGpPWpGaD
Promethazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000103	0.0029	CbGpPWpGaD
Promethazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000103	0.00289	CbGpPWpGaD
Promethazine—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000101	0.00284	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ITPKC—Kawasaki disease	9.82e-05	0.00276	CbGpPWpGaD
Promethazine—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	9.76e-05	0.00274	CbGpPWpGaD
Promethazine—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	9.76e-05	0.00274	CbGpPWpGaD
Promethazine—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	9.75e-05	0.00274	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—FCGR2A—Kawasaki disease	9.55e-05	0.00269	CbGpPWpGaD
Promethazine—CALM3—Signaling by VEGF—VEGFA—Kawasaki disease	9.53e-05	0.00268	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ITPKC—Kawasaki disease	9.26e-05	0.0026	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—FCGR2A—Kawasaki disease	9.24e-05	0.0026	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—FCGR2A—Kawasaki disease	9.24e-05	0.0026	CbGpPWpGaD
Promethazine—CALM1—Signaling by VEGF—VEGFA—Kawasaki disease	9.21e-05	0.00259	CbGpPWpGaD
Promethazine—CALM2—Signaling by VEGF—VEGFA—Kawasaki disease	9.21e-05	0.00259	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ITPKC—Kawasaki disease	9.18e-05	0.00258	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	8.99e-05	0.00253	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—BLK—Kawasaki disease	8.9e-05	0.0025	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	8.83e-05	0.00248	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—BLK—Kawasaki disease	8.61e-05	0.00242	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—BLK—Kawasaki disease	8.61e-05	0.00242	CbGpPWpGaD
Promethazine—DRD2—GPCR ligand binding—CCR5—Kawasaki disease	8.12e-05	0.00228	CbGpPWpGaD
Promethazine—HTR2A—GPCR ligand binding—CCR5—Kawasaki disease	7.99e-05	0.00225	CbGpPWpGaD
Promethazine—HRH1—GPCR ligand binding—CCR5—Kawasaki disease	7.97e-05	0.00224	CbGpPWpGaD
Promethazine—CHRM1—GPCR ligand binding—CCR5—Kawasaki disease	7.94e-05	0.00223	CbGpPWpGaD
Promethazine—CHRM3—GPCR ligand binding—CCR5—Kawasaki disease	7.92e-05	0.00223	CbGpPWpGaD
Promethazine—CHRM2—GPCR ligand binding—CCR5—Kawasaki disease	7.84e-05	0.00221	CbGpPWpGaD
Promethazine—ADRA1A—GPCR ligand binding—CCR5—Kawasaki disease	7.82e-05	0.0022	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CD40—Kawasaki disease	7.4e-05	0.00208	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CD40—Kawasaki disease	7.15e-05	0.00201	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CD40—Kawasaki disease	7.15e-05	0.00201	CbGpPWpGaD
Promethazine—CHRM4—GPCR downstream signaling—CCR5—Kawasaki disease	6.66e-05	0.00187	CbGpPWpGaD
Promethazine—CHRM5—GPCR downstream signaling—CCR5—Kawasaki disease	6.38e-05	0.00179	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—CCR5—Kawasaki disease	6.37e-05	0.00179	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—CCR5—Kawasaki disease	6.05e-05	0.0017	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—CCR5—Kawasaki disease	5.79e-05	0.00163	CbGpPWpGaD
Promethazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	5.65e-05	0.00159	CbGpPWpGaD
Promethazine—CALM3—Immune System—FCGR2A—Kawasaki disease	5.56e-05	0.00156	CbGpPWpGaD
Promethazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	5.46e-05	0.00154	CbGpPWpGaD
Promethazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	5.46e-05	0.00154	CbGpPWpGaD
Promethazine—CALM3—Immune System—BLK—Kawasaki disease	5.4e-05	0.00152	CbGpPWpGaD
Promethazine—CALM1—Immune System—FCGR2A—Kawasaki disease	5.38e-05	0.00151	CbGpPWpGaD
Promethazine—CALM2—Immune System—FCGR2A—Kawasaki disease	5.38e-05	0.00151	CbGpPWpGaD
Promethazine—CALM2—Immune System—BLK—Kawasaki disease	5.22e-05	0.00147	CbGpPWpGaD
Promethazine—CALM1—Immune System—BLK—Kawasaki disease	5.22e-05	0.00147	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—CRP—Kawasaki disease	4.96e-05	0.0014	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	4.81e-05	0.00135	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—CRP—Kawasaki disease	4.8e-05	0.00135	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—CRP—Kawasaki disease	4.8e-05	0.00135	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—CCR5—Kawasaki disease	4.59e-05	0.00129	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—CCR5—Kawasaki disease	4.51e-05	0.00127	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—CCR5—Kawasaki disease	4.5e-05	0.00127	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—CCR5—Kawasaki disease	4.49e-05	0.00126	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD40—Kawasaki disease	4.49e-05	0.00126	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—CCR5—Kawasaki disease	4.48e-05	0.00126	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—CCR5—Kawasaki disease	4.43e-05	0.00125	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—CCR5—Kawasaki disease	4.42e-05	0.00124	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD40—Kawasaki disease	4.34e-05	0.00122	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD40—Kawasaki disease	4.34e-05	0.00122	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—CCR5—Kawasaki disease	4.17e-05	0.00117	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—CCR5—Kawasaki disease	4.1e-05	0.00115	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—CCR5—Kawasaki disease	4.09e-05	0.00115	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—CCR5—Kawasaki disease	4.08e-05	0.00115	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—CCR5—Kawasaki disease	4.06e-05	0.00114	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—CCR5—Kawasaki disease	4.02e-05	0.00113	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—CCR5—Kawasaki disease	4.01e-05	0.00113	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CCR5—Kawasaki disease	3.57e-05	0.001	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MMP9—Kawasaki disease	3.48e-05	0.000979	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CCR5—Kawasaki disease	3.42e-05	0.000962	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—CCR5—Kawasaki disease	3.4e-05	0.000957	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—CD4—Kawasaki disease	3.35e-05	0.000943	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—CCR5—Kawasaki disease	3.29e-05	0.000926	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—CCR5—Kawasaki disease	3.29e-05	0.000926	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—CD4—Kawasaki disease	3.24e-05	0.000912	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—CD4—Kawasaki disease	3.24e-05	0.000912	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—CD4—Kawasaki disease	3.22e-05	0.000905	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—VEGFA—Kawasaki disease	3.13e-05	0.000879	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—CD4—Kawasaki disease	3.11e-05	0.000876	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—CD4—Kawasaki disease	3.11e-05	0.000876	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—VEGFA—Kawasaki disease	2.91e-05	0.000819	CbGpPWpGaD
Promethazine—CALM3—Immune System—CRP—Kawasaki disease	2.89e-05	0.000813	CbGpPWpGaD
Promethazine—CALM3—Disease—CCR5—Kawasaki disease	2.87e-05	0.000807	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—VEGFA—Kawasaki disease	2.82e-05	0.000792	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—VEGFA—Kawasaki disease	2.82e-05	0.000792	CbGpPWpGaD
Promethazine—CALM2—Immune System—CRP—Kawasaki disease	2.8e-05	0.000786	CbGpPWpGaD
Promethazine—CALM1—Immune System—CRP—Kawasaki disease	2.8e-05	0.000786	CbGpPWpGaD
Promethazine—CALM2—Disease—CCR5—Kawasaki disease	2.78e-05	0.000781	CbGpPWpGaD
Promethazine—CALM1—Disease—CCR5—Kawasaki disease	2.78e-05	0.000781	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCR5—Kawasaki disease	2.46e-05	0.000692	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCR5—Kawasaki disease	2.42e-05	0.000681	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCR5—Kawasaki disease	2.42e-05	0.000679	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCR5—Kawasaki disease	2.41e-05	0.000677	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCR5—Kawasaki disease	2.4e-05	0.000675	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCR5—Kawasaki disease	2.38e-05	0.000669	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCR5—Kawasaki disease	2.37e-05	0.000667	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCR5—Kawasaki disease	2.01e-05	0.000565	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP9—Kawasaki disease	1.95e-05	0.000549	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD4—Kawasaki disease	1.95e-05	0.000549	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCR5—Kawasaki disease	1.94e-05	0.000547	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCR5—Kawasaki disease	1.94e-05	0.000547	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD4—Kawasaki disease	1.89e-05	0.000531	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD4—Kawasaki disease	1.89e-05	0.000531	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP9—Kawasaki disease	1.87e-05	0.000526	CbGpPWpGaD
Promethazine—CALM3—Disease—CD4—Kawasaki disease	1.8e-05	0.000507	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—VEGFA—Kawasaki disease	1.75e-05	0.000493	CbGpPWpGaD
Promethazine—CALM2—Disease—CD4—Kawasaki disease	1.74e-05	0.00049	CbGpPWpGaD
Promethazine—CALM1—Disease—CD4—Kawasaki disease	1.74e-05	0.00049	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—VEGFA—Kawasaki disease	1.68e-05	0.000472	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—Kawasaki disease	1.35e-05	0.000378	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—Kawasaki disease	1.32e-05	0.000372	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—Kawasaki disease	1.32e-05	0.000372	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—Kawasaki disease	1.32e-05	0.00037	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—Kawasaki disease	1.31e-05	0.000369	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—Kawasaki disease	1.3e-05	0.000366	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—Kawasaki disease	1.3e-05	0.000365	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—Kawasaki disease	1.21e-05	0.00034	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—Kawasaki disease	1.19e-05	0.000334	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—Kawasaki disease	1.19e-05	0.000334	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—Kawasaki disease	1.18e-05	0.000333	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—Kawasaki disease	1.18e-05	0.000331	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—Kawasaki disease	1.17e-05	0.000328	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—Kawasaki disease	1.16e-05	0.000327	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—Kawasaki disease	1.1e-05	0.000309	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—Kawasaki disease	1.06e-05	0.000299	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—Kawasaki disease	1.06e-05	0.000299	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—Kawasaki disease	9.87e-06	0.000278	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—Kawasaki disease	9.55e-06	0.000268	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—Kawasaki disease	9.55e-06	0.000268	CbGpPWpGaD
